dc.contributor.author | Garcia-Garcia, Laura | |
dc.contributor.author | Fernández-Tabanera, Enrique | |
dc.contributor.author | Cervera Mayor, Saint Thomas | |
dc.contributor.author | Melero-Fernández de Mera, Raquel M | |
dc.contributor.author | Josa, Santiago | |
dc.contributor.author | Gonzalez-Gonzalez, Laura | |
dc.contributor.author | Rodriguez-Martin, Carlos | |
dc.contributor.author | Grünewald, Thomas G P | |
dc.contributor.author | Alonso, Javier | |
dc.date.accessioned | 2021-12-20T13:36:14Z | |
dc.date.available | 2021-12-20T13:36:14Z | |
dc.date.issued | 2021-11-12 | |
dc.identifier.citation | Cancers (Basel). 2021 Nov 12;13(22):5668. | es_ES |
dc.identifier.issn | 2072-6694 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/13499 | |
dc.description.abstract | Ewing sarcoma is a rare pediatric tumor characterized by chromosomal translocations that give rise to aberrant chimeric transcription factors (e.g., EWSR1-FLI1). EWSR1-FLI1 promotes a specific cellular transcriptional program. Therefore, the study of EWSR1-FLI1 target genes is important to identify critical pathways involved in Ewing sarcoma tumorigenesis. In this work, we focused on the transcription factors regulated by EWSR1-FLI1 in Ewing sarcoma. Transcriptomic analysis of the Ewing sarcoma cell line A673 indicated that one of the genes more strongly upregulated by EWSR1-FLI1 was FEZF1 (FEZ family zinc finger protein 1), a transcriptional repressor involved in neural cell identity. The functional characterization of FEZF1 was performed in three Ewing sarcoma cell lines (A673, SK-N-MC, SK-ES-1) through an shRNA-directed silencing approach. FEZF1 knockdown inhibited clonogenicity and cell proliferation. Finally, the analysis of the FEZF1-dependent expression profile in A673 cells showed several neural genes regulated by FEZF1 and concomitantly regulated by EWSR1-FLI1. In summary, FEZF1 is transcriptionally regulated by EWSR1-FLI1 in Ewing sarcoma cells and is involved in the regulation of neural-specific genes, which could explain the neural-like phenotype observed in several Ewing sarcoma tumors and cell lines. | es_ES |
dc.description.sponsorship | This research was funded by the Instituto de Salud Carlos III, grant numbers PI20CIII/00020, DTS18CIII/00005, PI16CIII/00026; Asociacion Pablo Ugarte, grant numbers TRPV205/18, TPI-M 1149/13; Asociación Candela Riera, Asociación Todos Somos Iván & Fundación Sonrisa de Alex, grant numbers TVP333-19, TVP-1324/15; ASION, grant number TVP141/17. R.M.M-FdM is supported for a grant of the Spanish Center for Biomedical Network Research on Rare Diseases (CIBERER). The laboratory of T.G.P.G. is supported by the Barbara and Wilfried Mohr Foundation. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | EWSR1-FLI1 | es_ES |
dc.subject | Ewing sarcoma | es_ES |
dc.subject | FEZF11 | es_ES |
dc.subject | GGAA-microsatellites | es_ES |
dc.title | The Transcription Factor FEZF1, a Direct Target of EWSR1-FLI1 in Ewing Sarcoma Cells, Regulates the Expression of Neural-Specific Genes | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 34830820 | es_ES |
dc.format.volume | 13 | es_ES |
dc.format.number | 22 | es_ES |
dc.format.page | 5668 | es_ES |
dc.identifier.doi | 10.3390/cancers13225668 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | Asociación Pablo Ugarte contra el cáncer infantil | es_ES |
dc.contributor.funder | Candela Ribera. Asociación contra el sarcoma de Ewing | es_ES |
dc.contributor.funder | Asociación Todos somos Iván | es_ES |
dc.contributor.funder | Centro de Investigación Biomedica en Red - CIBER | es_ES |
dc.contributor.funder | Fundación la Sonrisa de Alex para la investigación y el tratamiento del sarcoma de Ewing | |
dc.description.peerreviewed | Sí | es_ES |
dc.relation.publisherversion | https://doi.org/10.3390/cancers13225668 | es_ES |
dc.identifier.journal | Cancers | es_ES |
dc.repisalud.centro | ISCIII::Instituto de Investigación de Enfermedades Raras | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI20-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2020)/PI20CIII/00020 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/DTS-ISCIII 2018 Modalidad Proyectos de Desarrollo Tecnológico en Salud Intramurales. (2018)/DTS18CIII/00005 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/ISCIII 2016 Modalidad Proyectos de Investigacion en Salud Intramurales. (2016)/PI16CIII/00026 | es_ES |